ACTIVE

APOTHEEK GILAIN

Financial year 2025 · Closed on 31/12/2025

Net result35,6 k €+24,7 %over 1 year
Gross margin124 k €+29,9 %over 1 year
Equity240,1 k €+17,4 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK GILAIN is a Private limited company incorporated in 2020. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Tienen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0746.508.634
Incorporation
25/04/2020
Legal form
Private limited company
Registered office
Gilainstraat 37
3300 Tienen · FlandreSee on map
Contributed capital
285 000,00 €
Latest accounts
31/12/2025
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin124 k €95,4 k €77,1 k €62,5 k €60,2 k €
EBITDA121,7 k €92,6 k €76,9 k €62,5 k €59,7 k €
Operating result51,6 k €21,2 k €6,5 k €-8,3 k €-57,2 k €
Net result35,6 k €28,5 k €-5,9 k €-21,7 k €-81,3 k €
Balance sheet
Equity240,1 k €204,6 k €176,1 k €182 k €203,7 k €
Total assets705,8 k €785,3 k €691,1 k €796,8 k €847,3 k €
Cash163,1 k €174,5 k €76 k €109,6 k €129,8 k €
Debts465,4 k €580,4 k €515 k €614,8 k €643,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active

Active mandates

Lise Tourwé

Director · since 03 avril 2025

Active
FARMASO

Director · since 25 avril 2020 · 0866.899.985

Represented by Sophie Van Molhem

Active
Tom Willems

Director · since 25 avril 2020

Active

Other companies at this address

Gilainstraat 37 3300 Tienen
CompanyCBE no.
FARMASO● Active
0866.899.985

Full financial information

Source · NBB
20252024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202225/04/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months21 months
Filing date09/06/202628/06/202530/07/202431/07/202329/07/2022
General meeting06/06/202607/06/202501/06/202403/06/202304/06/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202506/06/202609/06/2026DutchPDF
Abridged model31/12/202407/06/202528/06/2025DutchPDF
Abridged model31/12/202301/06/202430/07/2024DutchPDF
Abridged model31/12/202203/06/202331/07/2023DutchPDF
Abridged model31/12/202104/06/202229/07/2022DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active

Active mandates

Lise Tourwé

Director · since 03 avril 2025

Active
FARMASO

Director · since 25 avril 2020 · 0866.899.985

Represented by Sophie Van Molhem

Active
Tom Willems

Director · since 25 avril 2020

Active

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates09/05/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other29/04/2020
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202535,6 k €↑
  2. 2024
    Annual accounts 202428,5 k €↑
  3. 2023
    Annual accounts 2023-5,9 k €↑
  4. 2022
    Annual accounts 2022-21,7 k €↑
  5. 2021
    Annual accounts 2021-81,3 k €
  6. 25/04/2020
    IncorporationPrivate limited company